Lin Z, Zhou W, Li S, Zhang Z
Zhonshan Ophthalmic Center, Sun Yat-Sen University of Medical Sciences, Guangzhou, China.
Yan Ke Xue Bao. 1994 Mar;10(1):57-9, 64.
We present 14 patients with secondary glaucoma following the implantation of a posterior chamber intraocular lens (IOLs). All patients were unilateral glaucoma, which developed within 1 month following the IOL implantation in 10 cases, and from 1 to 3 years in 4 cases. The angle of anterior chamber was open in 8 patients, and close in 6 ones. Seven patients required treatment of antiglaucomatous medicine; 4 patients underwent laser iridectomy and 3 patients required antiglaucoma surgery. The results showed that the corrected visual acuity was more than 0.5 in 28% of the patients before antiglaucoma treatment and in 50% of the patients after treatment. The main cause of poor vision is glaucomatous optic nerve atrophy. It suggests that it is important to find glaucoma early.
我们报告了14例植入后房型人工晶状体（IOL）后发生继发性青光眼的患者。所有患者均为单眼青光眼，其中10例在IOL植入后1个月内发病，4例在1至3年内发病。8例患者前房角开放，6例关闭。7例患者需要使用抗青光眼药物治疗；4例患者接受了激光虹膜切除术，3例患者需要进行抗青光眼手术。结果显示，在抗青光眼治疗前，28%的患者矫正视力大于0.5，治疗后这一比例为50%。视力不佳的主要原因是青光眼性视神经萎缩。这表明早期发现青光眼很重要。
